Related Experiment Video
Updated: Oct 22, 2025
06:03
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
1.5K
Isolated Tachycardia Presenting After Pfizer-BioNTech COVID-19 Vaccination
Charles Tate1, Luay Demashkieh2, Wael Hakmeh3
1Emergency Medicine, Chicago Medical School at Rosalind Franklin University of Medicine and Science, North Chicago, USA.
Cureus
|September 1, 2021
Summary
The first documented case of rapid heart rate and palpitations occurred hours after the Pfizer-BioNTech COVID-19 vaccine. This benign side effect resolved within 24 hours for the patient.
Area of Science:
- Immunology
- Cardiology
- Vaccinology
Background:
- Vaccine administration is associated with various potential side effects.
- The Pfizer-BioNTech COVID-19 vaccine is widely administered globally.
- Understanding post-vaccination adverse events is crucial for public health.
Observation:
- A 29-year-old woman experienced palpitations and tachycardia (heart rate >140 bpm).
- Symptom onset occurred 6-8 hours after her second COVID-19 vaccine dose.
- No other symptoms or signs were reported.
Findings:
- This case represents the first documented instance of isolated tachycardia and palpitations following the Pfizer-BioNTech COVID-19 vaccination.
- The observed symptoms were transient, resolving within 24 hours.
- The patient had no other concurrent health issues or symptoms.
Implications:
- Healthcare providers should be aware of this potential, albeit rare, benign side effect of the Pfizer-BioNTech vaccine.
- Prompt recognition and reassurance can prevent unnecessary patient anxiety and medical interventions.
- Further monitoring may be warranted to determine the incidence and full spectrum of this reaction.
Related Concept Videos
01:17Increased pulse rate
799
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
799
01:28Dysrhythmias II: Classification of Tachyarrhythmias
207
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
207
01:29Dysrhythmias III: Characteristics of Dysrhythmias
174
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
174
01:27Myocarditis II: Clinical Features and Diagnostic Tests
49
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
49
01:14Myocarditis III: Medical Management
32
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
32
01:20Desensitization and Tachyphylaxis
2.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.5K